Evidence map›Paper›PMID 37231849›Full record

ArticleEuropean addiction research2023

Cannabis Consumers' View of Regulated Access to Recreational Cannabis: A Multisite Survey in Switzerland.

Monika Müller, Edith Paula Mészáros, Marc Walter, Lavinia Baltes-Flückiger, Marcus Herdener, Reto Auer, Gabriel Thorens, Stephane Rothen, Carlos Nordt, Daniele Zullino

Open access · hybridAbstract read
In one paragraph

Article in European addiction research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Monika MüllerDepartment of Mental Health and Psychiatry, Service of Addiction Medicine, University Hospitals Geneva, Geneva, Switzerland.
Edith Paula MészárosDepartment of Mental Health and Psychiatry, Service of Addiction Medicine, University Hospitals Geneva, Geneva, Switzerland, meszaros.edith.paula@gmail.com.
Marc WalterPsychiatric and Psychotherapeutic Clinic, Psychiatric Services Aargau, Windisch, Switzerland.
Lavinia Baltes-FlückigerPsychiatric and Psychotherapeutic Clinic, Psychiatric Services Aargau, Windisch, Switzerland.
Marcus HerdenerCenter for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland.
Reto AuerInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Gabriel ThorensDepartment of Mental Health and Psychiatry, Service of Addiction Medicine, University Hospitals Geneva, Geneva, Switzerland.
Stephane RothenDepartment of Mental Health and Psychiatry, Service of Addiction Medicine, University Hospitals Geneva, Geneva, Switzerland.
Carlos NordtCenter for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland.
Daniele ZullinoDepartment of Mental Health and Psychiatry, Service of Addiction Medicine, University Hospitals Geneva, Geneva, Switzerland.
University Hospital of Geneva · CHPsychiatry Baselland · CHUniversity Psychiatric Hospital · SIGeneva College · USUniversity Hospital of Bern · CHUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is considerable effort in legalizing recreational use of cannabis globally. The successful implementation of a program of regulated access to recreational cannabis (PRAC) depends on the consumers' engagement. The aim of this study was to examine the acceptability of twelve different regulatory aspects by cannabis users including those obtaining cannabis from the illicit market and vulnerable populations such as young adults and problematic users.

methodsThe current study is a multisite online survey conducted in Switzerland. A total of 3,132 adult Swiss residents who consumed cannabis within the previous 30 days represented the studied population. Mean age was 30.5 years, 80.5% were men, and 64.2% of the participants stated that they always or often obtain cannabis from the illicit market. We described consumers' acceptability of twelve regulatory aspects concerning THC content control, disclosure of sensitive personal data, security aspects, and follow-up procedures by applying descriptive statistics and multiple regression models.

resultsTHC content regulation showed most discrepancy with 89.4% of the participants stating to engage in a PRAC if five different THC contents were available as compared to 54% if only 12% THC was available. The least accepted regulatory aspect was disposal of contact details with an acceptability rate of 18.1%. Consumers mainly obtaining cannabis from the illicit market, young adults, and problematic users showed similar acceptability patterns. Participants obtaining cannabis from the illicit market were more likely to engage in a PRAC if five different THC contents were available as compared to participants obtaining cannabis from other sources (OR 1.94, 95% CI: 1.53-2.46).

conclusionA carefully designed PRAC that takes into account the consumers' perspective is likely to transfer them to the regulated market and to engage vulnerable populations. We cannot recommend the distribution of cannabis with only 12% THC content as this is unlikely to engage the target population.

Indexed as

CannabisMarijuana SmokingAdultFemaleHumansMaleSurveys and QuestionnairesSwitzerlandYoung AdultCannabis legalizationCannabis policyRecreational cannabisRegulated access to cannabis

Identifiers

PMID37231849
PMCPMC10389784
OpenAlexW4378348170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.